| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 0.7 | 0.3 | 0.0 |
| Total income | 0.7 | 0.3 | 0.0 |
| Profit before exceptional items & tax | -0.1 | -0.1 | -0.0 |
| Profit before tax | -0.1 | -0.1 | -0.0 |
| Net profit | -0.1 | -0.1 | -0.0 |
| Operating margin | -14.3% | -33.3% | 0.0% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
BSE results filing, NSE: VINRKLB. Figures extracted from the filing.
Rekvina Laboratories Ltd: key numbers
- Share price
- ₹49.90
- Market cap
- ₹30.08 Cr
- Revenue (annual)
- ₹1.27 Cr
- Net profit (annual)
- ₹-0.25 Cr
- P/E (TTM)
- -88.5×Sector 50.4×
- Promoter holding
- 77.00%+35.70% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Rekvina Laboratories Ltd
All →Rekvina Laboratories Management Change
Rekvina Laboratories Ltd announced a change in its registered office within the city and the resignation of its Managing Director, Mr. Amit Shah.
Rekvina Laboratories Management Change
Mr. Amit Mukesh Shah has resigned as Managing Director and Director of Rekvina Laboratories Limited, effective September 11, 2026.
Rekvina Laboratories Other Announcement
The company filed its shareholding pattern reporting changes in share distribution following the recent open offer. The public shareholding has fallen below the minimum threshold.
Rekvina Laboratories Board Meeting Outcome
Rekvina Laboratories' board meeting approved the Annual Report for FY2025-26 and the notice for the upcoming AGM. It also noted the resignation of the Company Secretary.
Rekvina Laboratories Annual General Meeting
Rekvina Laboratories' 38th AGM will be held online on September 29, 2026. The board also approved the notice and noted the company secretary's resignation.
Rekvina Laboratories Management Change
Mr. Deepak Khandelwal has resigned from his position as Company Secretary and Compliance Officer of Rekvina Laboratories Limited, effective from September 2, 2026.